Anika Therapeutics (ANIK) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.41 +0.21%
Revenue Growth %: +3.5%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
CRMT, REPL, HURC, More
Revenue Growth %: +3.5%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.00, $0.35 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.5 million versus the consensus estimate of $38.27 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Are we witnessing a fundamental or speculative rally in the S&P 500?
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
